MELATONIN M/R 1mg and 5mg tablets (Slenyto ®)
Clinical Indication
Treatment of insomnia not covered by the yellow status
Date of classification
August 2019
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.